Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

21. Joint Statement: Recent Developments Regarding COVID-19 and Pregnant Women

, the CDC continues to recognize that pregnant women have been at risk for severe illness, morbidity, or mortality compared with the general population in other related coronavirus infections (including severe acute respiratory syndrome coronavirus (SARS-CoV). The CDC’s current guidance regarding COVID-19 and pregnancy is based on limited data, which, at this point, does not indicate that pregnancy alone puts people at higher risk for severe illness resulting from COVID-19 infection. Limited data (...) Joint Statement: Recent Developments Regarding COVID-19 and Pregnant Women Joint Statement: Recent Developments Regarding COVID-19 and Pregnant Women — April 6, 2020 — The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine are aware that the Centers for Disease Control and Prevention (CDC) recently removed pregnant people from their webpage that outlines “people who are at higher risk for severe illness” from COVID-19. Consistent with available data

2020 American College of Obstetricians and Gynecologists

22. Physical Activity and Exercise During Pregnancy and the Postpartum Period

activity or who were physically active before pregnancy can continue these activities during pregnancy and the postpartum period. Additionally, women who are pregnant should be under the care of an obstetrician-gynecologist or other obstetric care provider who can monitor the progress of the pregnancy. Women who are pregnant can consult their obstetrician–gynecologist or other obstetric care provider about whether or how to adjust their physical activity during pregnancy and postpartum . Physical (...) . In the absence of obstetric or medical complications or contraindications, physical activity in pregnancy is safe and desirable, and pregnant women should be encouraged to continue or to initiate safe physical activities , . Box 1. Examples of Exercises That Have Been Extensively Studied in Pregnancy and Found to Be Safe and Beneficial Walking Stationary cycling Aerobic exercises Dancing Resistance exercises (eg, using weights, elastic bands) Stretching exercises Hydrotherapy, water aerobics Modified from

2020 American College of Obstetricians and Gynecologists

23. Impact of music therapy before first-trimester instrumental termination of pregnancy: a randomised controlled trial

Impact of music therapy before first-trimester instrumental termination of pregnancy: a randomised controlled trial Impact of Music Therapy Before First-Trimester Instrumental Termination of Pregnancy: A Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable (...) Create file Cancel Actions Cite Share Permalink Copy Page navigation BJOG Actions . 2020 May;127(6):738-745. doi: 10.1111/1471-0528.16102. Epub 2020 Feb 14. Impact of Music Therapy Before First-Trimester Instrumental Termination of Pregnancy: A Randomised Controlled Trial , , , , , Affiliations Expand Affiliation 1 Department of Obstetrics and Gynaecology, University Hospital of Angers, Angers, France. PMID: 31957130 DOI: Item in Clipboard Impact of Music Therapy Before First-Trimester Instrumental

2020 EvidenceUpdates

24. Effect of High-Dose vs Standard-Dose Vitamin D Supplementation in Pregnancy on Bone Mineralization in Offspring Until Age 6 Years: A Prespecified Secondary Analysis of a Double-Blinded, Randomized Clinical Trial

mineralization, but investigations are few and with mixed results. Objective: To investigate the effect of a high dose vs standard dose of vitamin D supplementation in pregnancy on anthropometric and bone outcomes until age 6 years in the offspring. Design, setting, and participants: A prespecified analysis of a double-blinded, randomized clinical trial in the Copenhagen Prospective Studies on Asthma in Childhood 2010 mother-child cohort that included 623 pregnant mothers and their 584 children. Data were (...) Effect of High-Dose vs Standard-Dose Vitamin D Supplementation in Pregnancy on Bone Mineralization in Offspring Until Age 6 Years: A Prespecified Secondary Analysis of a Double-Blinded, Randomized Clinical Trial Effect of High-Dose vs Standard-Dose Vitamin D Supplementation in Pregnancy on Bone Mineralization in Offspring Until Age 6 Years: A Prespecified Secondary Analysis of a Double-Blinded, Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable

2020 EvidenceUpdates

25. Mindfetalness to increase women's awareness of fetal movements and pregnancy outcomes: a cluster-randomised controlled trial including 39 865 women Full Text available with Trip Pro

Mindfetalness to increase women's awareness of fetal movements and pregnancy outcomes: a cluster-randomised controlled trial including 39 865 women Mindfetalness to Increase Women's Awareness of Fetal Movements and Pregnancy Outcomes: A Cluster-Randomised Controlled Trial Including 39 865 Women - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History (...) Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation BJOG Actions . 2020 Jan 23. doi: 10.1111/1471-0528.16104. Online ahead of print. Mindfetalness to Increase Women's Awareness of Fetal Movements and Pregnancy Outcomes: A Cluster-Randomised Controlled Trial Including 39 865 Women , , , , , , Affiliations Expand Affiliations 1 Department of Women and Children's Health, Karolinska Institutet, Sophiahemmet University, Stockholm

2020 EvidenceUpdates

26. Genome-wide microarray testing for pregnancies with major foetal structual abnormalities detected by ultrasound

) for a type of genetic testing that would be done during pregnancy. The test, called genome-wide microarray, would be done if a pregnant woman had an ultrasound that has shown the unborn baby has a major structural abnormality (sometimes called a birth defect). 2 Currently, these structural abnormalities are further assessed by a type of genetic test called karyotyping. Genome-wide microarray is a new pathology laboratory tool used to analyse large numbers of genes at one time. The evidence provided (...) Genome-wide microarray testing for pregnancies with major foetal structual abnormalities detected by ultrasound 1 Public Summary Document Application No. 1533 – Genome-wide microarray testing for pregnancies with major fetal structural abnormalities detected by ultrasound Applicant: The Royal College of Pathologists of Australasia (RCPA) Date of MSAC consideration: MSAC 77 th Meeting, 28-29 November 2019 Context for decision: MSAC makes its advice in accordance with its Terms of Reference

2020 Medical Services Advisory Committee

27. Cannabis Use During Pregnancy and Lactation: A Practice Resources for Health Care Providers

in a parenting and human-milk-feeding relationship with a child who may not self-identify as such. Health care providers may prefer to use the term “chestfeeding” rather than breastfeeding in these cases. This practice resource is intended for the use of health care providers providing clinical care and/or counselling to women and pregnant individuals in the perinatal period. The purpose of this practice resource is to help health care providers facilitate conversations on cannabis use during pregnancy (...) to avoid or reduce using any forms of cannabis during pregnancy and lactation due to the lack of information on the short- and long-term effects on women and pregnant individuals' health and children’s growth and development. THC tetrahydrocannabinol CBD cannabinol Cannabis Use During Pregnancy & Lactation I Practice Resource for Health Care Providers I February 2020 What is Cannabis? Cannabis refers to substances derived from the plant Cannabis sativa and is composed of two main compounds: delta-9

2020 British Columbia Perinatal Health Program

28. Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease

in the context of Ebola virus disease 3 Executive summary The Democratic Republic of Congo is currently experiencing the second largest Ebola outbreak in history (1), following a 2014-2016 outbreak in western Africa that had an estimated 28,000 cases. Investigational treatment and vaccination trials are ongoing, but data in the context of pregnancy and breastfeeding are limited (2,3). A paucity of scientific evidence exists on how to best treat pregnant or breastfeed - ing women with suspected or confirmed (...) work with pregnant or breastfeeding women in the context of Ebola. The guidelines are relevant to the WHO goal of ensuring one billion people are better protected from health emergen- cies by impacting maternal mortality, neonatal survival, and the transmission Ebola virus in the context of an Ebola epidemic. Specific recommendations cover 6 topics. These are: (i) the management of acute EVD in pregnant women, (ii) the management of pregnancies in women who develop EVD during pregnancy and those

2020 World Health Organisation Guidelines

29. Valproate (Epilim, Depakote) pregnancy prevention programme: updated educational materials

Valproate (Epilim, Depakote) pregnancy prevention programme: updated educational materials Valproate (Epilim▼, Depakote▼) pregnancy prevention programme: updated educational materials - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Valproate (Epilim▼, Depakote (...) ▼) pregnancy prevention programme: updated educational materials In January 2020, healthcare professionals received updated educational materials to support the valproate pregnancy prevention programme. Valproate is contraindicated in girls and women of childbearing potential, unless the conditions of the pregnancy prevention programme are met. Published 12 February 2020 From: Therapeutic area: , , , Contents Advice for healthcare professionals: valproate is contraindicated in girls and women

2020 MHRA Drug Safety Update

30. Severe vomiting in pregnancy: the priority is to rehydrate

antihistamine (despite its limitations) in mild nausea and vomiting in a pregnant woman. Priority treatment of severe vomiting during pregnancy consists of non-drug measures, chiefly parenteral rehydration combined with rest. Of the antiemetic drugs with proven efficacy in other situations, metoclopramide is the one for which we have the longest experience during the first trimester of pregnancy, with no major signal of an increased malformation rate. But after the first trimester, the long-term (...) Severe vomiting in pregnancy: the priority is to rehydrate Prescrire IN ENGLISH - Spotlight ''Severe vomiting in pregnancy: the priority is to rehydrate'', 1 February 2020 {1} {1} {1} | | > > > Severe vomiting in pregnancy: the priority is to rehydrate Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Severe vomiting in pregnancy: the priority

2020 Prescrire

31. Vaccination in pregnancy (VIP)

Vaccination in pregnancy (VIP) Vaccination in pregnancy (VIP) - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Guidance Vaccination in pregnancy (VIP) Advice for GPs on pregnant women who are inadvertently vaccinated against measles, mumps, rubella, chicken pox (...) (varicella) or human papilloma virus. Published 1 May 2010 Last updated 21 January 2020 — From: Contents The Immunisation department at Public Health England ( ( . . Shingles vaccine administration in pregnancy Shingles vaccine (Zostavax®, Generic Name: Varicella Zoster Virus, Marketed by Sanofi Pasteur MSD) is a live viral vaccine that is not recommended for use in pregnancy. Most women of child-bearing age in the UK are known to be immune to chickenpox. You can reassure a pregnant woman immunised

2020 Public Health England

32. Towards integrated antenatal care for low-risk pregnancy

engaged in non-clinical interventions 28 3.2.4 How to improve BPPE: Literature review and stakeholders consultation 28 3.3 ICT INNOVATIONS FOR INFORMATION EXCHANGE 31 4 LEGAL FRAMEWORK OF ANC AND PROTECTIVE MEASURES FOR PREGNANT WOMEN IN BELGIUM 33 4.1 LEGAL FRAMEWORK OF ANC IN BELGIUM 33 4.2 PROTECTIVE MEASURES FOR (VULNERABLE) PREGNANT WOMEN 34 2 Towards integrated antenatal care for low-risk pregnancy KCE Report 326 5 PROVISION AND UPTAKE OF ROUTINE ANC: PARENTS’ AND HEALTHCARE PROFESSIONALS (...) Recommendations 82 4 Towards integrated antenatal care for low-risk pregnancy KCE Report 326 LIST OF FIGURES Figure 1 – Evolution of the average length of stay (in days) for deliveries with a low level of severity (SOI 1) in Belgium (2 nd semester 2013 - 2 nd semester 2017 [last data available]) 14 Figure 2 – Proportion of low-risk pregnant women who attended at least one consultation during their pregnancy by healthcare professional, in 2016 19 Figure 3 – Number of ANC consultations (2016) for clinical

2020 Belgian Health Care Knowledge Centre

33. Pregnancy Health: Exercise Programs to Prevent Gestational Hypertension

: Exercise Programs to Prevent Gestational Hypertension Tabs Snapshot Summary of CPSTF Finding The exercise programs for pregnant women to reduce the development of gestational hypertension. Intervention Programs engage women in regular exercise from before their 16th week of pregnancy through birth. Exercise programs must include one or both of the following: Supervised exercise classes that meet at least three times each week and include 30-60 minutes of moderate-intensity aerobic exercise Regular (...) . Exercise during pregnancy protects against hypertension and macrosomia: randomized clinical trial. Am J Obstet Gynecol . 2016;214:649.e1–8. de Oliveria Melo AS, Silva JL, Tavares JS, Barros VO, Leite DF, Amorim MM. Effect of a physical exercise program during pregnancy on uteroplacental and fetal blood flow and fetal growth: a randomized controlled trial. Obstet Gynecol . 2012;120:302–10. Haakstad LAH, Bo K. Exercise in pregnant women and birth weight: a randomized controlled trial. BMC Pregnancy

2020 Community Preventive Services Task Force

34. Diabetes in Pregnancy

Diabetes in Pregnancy Guideline No. 393-Diabetes in Pregnancy - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 41, Issue 12, Pages 1814–1825.e1 Guideline No. 393-Diabetes in Pregnancy x Howard Berger Correspondence Corresponding author: Dr. Howard Berger , MD x Howard Berger Correspondence Corresponding author: Dr. Howard Berger Toronto, ON x Robert Gagnon , MD Montréal, QC x Mathew Sermer , MD Toronto, ON No. 393 (...) , December 2019 (replaces No. 334, July 2016) DOI: To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Figures Appendix A Gestational Diabetes Mellitus Screening and Diagnosis Appendix B Gestational Diabetes Mellitus Postpartum Testing Abstract Objectives This guideline reviews the evidence relating to the diagnosis and obstetrical management of diabetes in pregnancy. Outcomes The outcomes evaluated were short and long-term maternal outcomes

2020 Society of Obstetricians and Gynaecologists of Canada

35. Maternal Collapse in Pregnancy and the Puerperium Full Text available with Trip Pro

Maternal Collapse in Pregnancy and the Puerperium Maternal Collapse in Pregnancy and the Puerperium - Chu - - BJOG: An International Journal of Obstetrics & Gynaecology - Wiley Online Library

2020 Royal College of Obstetricians and Gynaecologists

36. Antiepileptics and pregnancy: potential long-term effects in children

and pregnancy: potential long-term effects in children FEATURED REVIEW Many women who could become pregnant are exposed to antiepileptic drugs. Yet most of the antiepileptic drugs taken by pregnant women expose the unborn child to the risk of malformations, fetotoxic effects and neonatal disorders. What are the long-term effects of the most widely used antieleptics on children exposed in utero, and how do they compare? Full review (8 pages) available for download by subscribers. Abstract What are the main (...) Antiepileptics and pregnancy: potential long-term effects in children Prescrire IN ENGLISH - Spotlight ''Antiepileptics and pregnancy: potential long-term effects in children'', 1 January 2020 {1} {1} {1} | | > > > Antiepileptics and pregnancy: potential long-term effects in children Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Antiepileptics

2020 Prescrire

37. Tuberculosis and pregnant women

Tuberculosis and pregnant women Tuberculosis and pregnant women - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Tuberculosis and pregnant women Guidance for patients and the public and for clinical staff involved in treating pregnant women. Published 1 November 2013 Last (...) . Please tell us what format you need. It will help us if you say what assistive technology you use. Details One set of guidance is for pregnant women and members of the public. The other is for clinical staff treating pregnant women who have had contact with a person with infectious tuberculosis ( 17 December 2019 Updated to reflect changes in national guidance and availability of services. 1 November 2013 First published. Related content Collection Explore the topic Is this page useful? Thank you

2020 Public Health England

38. Are healthy weight management interventions effective before, during and after pregnancy?

management interventions before, during and after pregnancy, including those that reduce gestational weight gain (GWG) or prevent poor maternal and child health outcomes, from January 1 st 2010 to 19 th Sept 2019. Key messages • There were many systematic reviews addressing this topic, but there was no overall consensus on which interventions are the most effective for healthy weight management in pregnant or postpartum women • Some reviews found that dietary interventions alone were significantly more (...) interventions before, during and after pregnancy? KLS Evidence Briefing 2 nd October 2019 Background The prevalence of obesity in pregnancy is increasing, rising from 9–10% in the early 1990s to 16–19% in the 2000s. Pregnant women who are obese are at greater risk of pregnancy-related complications compared with women of normal BMI, including pre-eclampsia, gestational diabetes and increased risk of caesarean birth (1). There is still a lack of consensus on the optimal gestational weight gain for obese

2020 Public Health England - Evidence Briefings

39. Restrictive versus routine episiotomy among Southeast Asian term pregnancies: a multicentre randomised controlled trial Full Text available with Trip Pro

Restrictive versus routine episiotomy among Southeast Asian term pregnancies: a multicentre randomised controlled trial Restrictive Versus Routine Episiotomy Among Southeast Asian Term Pregnancies: A Multicentre Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily (...) : Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation BJOG Actions , 127 (3), 397-403 Feb 2020 Restrictive Versus Routine Episiotomy Among Southeast Asian Term Pregnancies: A Multicentre Randomised Controlled Trial , , , , , , , , Affiliations Expand Affiliations 1 Department of Obstetrics and Gynaecology, Khon Kaen Hospital, Khon Kaen, Thailand. 2

2020 EvidenceUpdates

40. Guidance on self-monitoring of blood pressure in pregnancy

Guidance on self-monitoring of blood pressure in pregnancy 1 Information for healthcare professionals Version 1: Published Monday 30 March 2020 Self-monitoring of blood pressure in pregnancy2 1. Introduction The COVID-19 pandemic has required the NHS to urgently consider blood pressure (BP) self-monitoring in order to reduce face to face consultations for pregnant and postnatal women, whilst maintaining adequate safety for the woman and her baby. BP self-monitoring in pregnancy can either (...) with chronic hypertension, based on their care outside of pregnancy. 1.1 Scope This guidance covers pregnant women who currently require blood pressure monitoring (at varying frequencies) throughout the antenatal and postnatal period, during the period of COVID-19 pandemic. For women with chronic hypertension, gestational hypertension or pre-eclampsia, more frequent BP monitoring is required, over and above standard antenatal care. Other groups of women may also require increased frequency if they have

2020 Royal College of Obstetricians and Gynaecologists